Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Suzuki

Showing results (111-120 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Antimicrobial Chemotherapy|October 27, 2023
Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only dataYuto Yamada, Takashi Niwa, Yurie Ono, et al.
Neuron|May 13, 2019
Reciprocal Activation within a Kinase-Effector Complex Underlying Persistence of Structural LTPTakeo Saneyoshi, Hitomi Matsuno, Akio Suzuki, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancerHideki Hayashi, Hirotoshi Iihara, Chiemi Hirose, et al.
Anticancer Research|January 9, 2021
Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or AfliberceptYunami Yamada, Nobuhisa Matsuhashi, Hironori Fujii, et al.
International Journal of Clinical Oncology|April 11, 2021
Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenibDaichi Watanabe, Hironori Fujii, Yunami Yamada, et al.
Frontiers in Medicine|March 31, 2023
Serum syndecan-1 concentration in hemolysis, elevated liver enzymes, and low platelets syndrome: A case reportAyane Nishio, Ryo Kamidani, Hideshi Okada, et al.
The Oncologist|March 13, 2020
Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective StudyHironori Fujii, Nobuhisa Matsuhashi, Mika Kitahora, et al.
Scientific Reports|August 7, 2023
Controlling nutritional status score during hospitalization as a predictor of clinical outcome in patients with aneurysmal subarachnoid hemorrhageShinya Shimizu, Tatsunori Hanai, Yusuke Egashira, et al.
Anticancer Research|December 8, 2020
Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric CancerHironori Fujii, Akitaka Makiyama, Hirotoshi Iihara, et al.
International Journal of Clinical Practice|December 13, 2019
Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastageHirotsugu Yamada, Ryo Kobayashi, Shinya Shimizu, et al.
Pageof 21

Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|October 27, 2023
Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only dataYuto Yamada, Takashi Niwa, Yurie Ono, et al.
Neuron|May 13, 2019
Reciprocal Activation within a Kinase-Effector Complex Underlying Persistence of Structural LTPTakeo Saneyoshi, Hitomi Matsuno, Akio Suzuki, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancerHideki Hayashi, Hirotoshi Iihara, Chiemi Hirose, et al.
Anticancer Research|January 9, 2021
Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or AfliberceptYunami Yamada, Nobuhisa Matsuhashi, Hironori Fujii, et al.
International Journal of Clinical Oncology|April 11, 2021
Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenibDaichi Watanabe, Hironori Fujii, Yunami Yamada, et al.
Frontiers in Medicine|March 31, 2023
Serum syndecan-1 concentration in hemolysis, elevated liver enzymes, and low platelets syndrome: A case reportAyane Nishio, Ryo Kamidani, Hideshi Okada, et al.
The Oncologist|March 13, 2020
Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective StudyHironori Fujii, Nobuhisa Matsuhashi, Mika Kitahora, et al.
Scientific Reports|August 7, 2023
Controlling nutritional status score during hospitalization as a predictor of clinical outcome in patients with aneurysmal subarachnoid hemorrhageShinya Shimizu, Tatsunori Hanai, Yusuke Egashira, et al.
Anticancer Research|December 8, 2020
Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric CancerHironori Fujii, Akitaka Makiyama, Hirotoshi Iihara, et al.
International Journal of Clinical Practice|December 13, 2019
Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastageHirotsugu Yamada, Ryo Kobayashi, Shinya Shimizu, et al.
Pageof 21